HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mayumi Nagata Selected Research

Melanoma (Melanoma, Malignant)

5/2021Edoxaban prevented adverse effects including pyrexia and elevation of D-dimer caused by the combination of BRAF and MEK inhibitors in a patient with BRAF-mutant melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mayumi Nagata Research Topics

Disease

9Psoriasis (Pustulosis Palmaris et Plantaris)
11/2022 - 03/2018
8Atopic Dermatitis (Atopic Eczema)
01/2023 - 06/2019
4Cataract (Cataracts)
12/2023 - 09/2008
4Chromosome Aberrations (Chromosome Abnormalities)
04/2015 - 08/2012
3Capsule Opacification
11/2023 - 03/2008
2Inflammation (Inflammations)
02/2023 - 10/2020
2Alopecia Areata
09/2021 - 06/2019
2Psoriatic Arthritis
02/2020 - 01/2020
1Focal Infection
03/2024
1Erythema
01/2023
1Rupture
09/2022
1Glaucoma-Related Pigment Dispersion Syndrome
09/2022
1Ingrown Nails (Ingrown Nail)
01/2022
1Pyogenic Granuloma
01/2022
1Paronychia
01/2022
1Obesity
11/2021
1Body Weight (Weight, Body)
11/2021
1Noncommunicable Diseases
11/2021
1Fever (Fevers)
05/2021
1Melanoma (Melanoma, Malignant)
05/2021
1Herpes Zoster
04/2021
1Neuralgia (Stump Neuralgia)
04/2021
1Eczema
09/2020
1Conjunctivitis
01/2020
1Infections
03/2018
1Pain (Aches)
02/2015
1Thymoma (Thymic Carcinoma)
02/2013
1Lichen Planus (Lichen Ruber Planus)
02/2013
1Rheumatoid Arthritis
12/2002
1Arthritis (Polyarthritis)
12/2002
1Inappropriate ADH Syndrome (SIADH)
12/2002

Drug/Important Bio-Agent (IBA)

6dupilumabIBA
01/2023 - 06/2019
4Capsules (Microcapsules)IBA
09/2022 - 03/2008
4carbendazimIBA
04/2015 - 08/2012
41,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
04/2015 - 08/2012
4Diethylnitrosamine (N-Nitrosodiethylamine)IBA
04/2015 - 08/2012
4ColchicineFDA LinkGeneric
04/2015 - 08/2012
3Biomarkers (Surrogate Marker)IBA
02/2023 - 10/2020
2ixekizumabIBA
11/2022 - 01/2020
2Chemokine CCL17IBA
10/2020 - 01/2020
1ConnexinsIBA
12/2023
1Aquaporins (Water Channels)IBA
12/2023
1upadacitinibIBA
01/2023
1Ivermectin (Mectizan)FDA Link
01/2023
1ErbB Receptors (EGF Receptor)IBA
01/2022
1SaponinsIBA
11/2021
1LipidsIBA
11/2021
1ChylomicronsIBA
11/2021
1Fatty Acids (Saturated Fatty Acids)IBA
11/2021
1Apolipoprotein B-48IBA
11/2021
1Glucose (Dextrose)FDA LinkGeneric
11/2021
1AntioxidantsIBA
11/2021
1PowdersIBA
11/2021
1hederageninIBA
11/2021
1Staphylococcal Protein A (Protein A)IBA
11/2021
1Triglycerides (Triacylglycerol)IBA
11/2021
1baricitinibIBA
09/2021
1binimetinibIBA
05/2021
1encorafenibIBA
05/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2021
1fibrin fragment D (D-dimer)IBA
05/2021
1edoxabanIBA
05/2021
1trametinibIBA
05/2021
1dabrafenibIBA
05/2021
1Interleukin-10 (Interleukin 10)IBA
04/2021
1ChemokinesIBA
10/2020
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
09/2020
1Messenger RNA (mRNA)IBA
08/2020
1Triiodothyronine (Liothyronine)FDA LinkGeneric
02/2020
1C-Reactive ProteinIBA
02/2020
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
02/2020
1Thyroxine (Levothyroxine)FDA LinkGeneric
02/2020
1Immunoglobulin E (IgE)IBA
01/2020
1Infliximab (Remicade)FDA Link
01/2020
1apremilastIBA
06/2019
1brodalumabIBA
03/2018
1Buprenorphine (Subutex)FDA LinkGeneric
02/2015
1Analgesics (Analgesic Drugs)IBA
02/2015
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
02/2015
1EtretinateFDA Link
02/2013
1mizoribineIBA
12/2002
1Vasopressins (Vasopressin)IBA
12/2002

Therapy/Procedure

4Intraocular Lenses (Intraocular Lens)
11/2023 - 03/2008
4Hepatectomy
04/2015 - 08/2012
1Phototherapy (Light Therapy)
03/2024
1Blood Component Removal (Apheresis)
11/2022
1Critical Care (Surgical Intensive Care)
06/2022
1Therapeutics
05/2021